HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaru Miyazaki Selected Research

KT 5720

7/20086-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (cilostazol), a phosphodiesterase type 3 inhibitor, reduces infarct size via activation of mitochondrial Ca2+-activated K+ channels in rabbit hearts.
1/2008Infarct size limitation by adrenomedullin: protein kinase A but not PI3-kinase is linked to mitochondrial KCa channels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaru Miyazaki Research Topics

Disease

160Neoplasms (Cancer)
04/2022 - 01/2002
51Neoplasm Metastasis (Metastasis)
05/2023 - 05/2003
36Pancreatic Neoplasms (Pancreatic Cancer)
10/2022 - 09/2002
32Hepatocellular Carcinoma (Hepatoma)
03/2024 - 05/2003
24Breast Neoplasms (Breast Cancer)
05/2017 - 01/2002
20Biliary Tract Neoplasms (Biliary Tract Cancer)
10/2022 - 01/2002
19Carcinoma (Carcinomatosis)
08/2020 - 01/2003
17Lymphatic Metastasis
01/2021 - 01/2003
17Cholangiocarcinoma
01/2019 - 10/2002
15Stomach Neoplasms (Stomach Cancer)
11/2015 - 04/2002
14Adenocarcinoma
07/2019 - 09/2002
14Colorectal Neoplasms (Colorectal Cancer)
06/2019 - 03/2002
13Klatskin Tumor
01/2023 - 04/2005
13Pathologic Constriction (Stenosis)
07/2019 - 10/2005
11Rectal Neoplasms (Rectal Cancer)
11/2015 - 05/2002
10Infections
01/2019 - 10/2002
10Ischemia
11/2016 - 01/2002
9Obstructive Jaundice (Cholestatic Jaundice)
06/2014 - 04/2005
8Thrombosis (Thrombus)
07/2017 - 01/2004
7Hemorrhage
02/2017 - 05/2003
7Liver Failure
01/2016 - 10/2004
7Bile Duct Neoplasms (Bile Duct Cancer)
03/2014 - 10/2005
6Inflammation (Inflammations)
01/2021 - 08/2002
6Ascites
01/2019 - 11/2006
6Cholangitis
03/2017 - 01/2008
5Liver Diseases (Liver Disease)
06/2020 - 01/2006
5Hyperbilirubinemia
02/2019 - 01/2008
5Head and Neck Neoplasms (Head and Neck Cancer)
05/2017 - 11/2014
5Fever (Fevers)
11/2015 - 01/2008
5Gallbladder Neoplasms (Gallbladder Cancer)
02/2014 - 01/2008
5Neuroendocrine Carcinoma
04/2010 - 01/2008
4Sigmoid Neoplasms
02/2019 - 11/2007
4Intestinal Obstruction (Obstruction, Intestinal)
11/2015 - 10/2007
4Noninfiltrating Intraductal Carcinoma (DCIS)
08/2014 - 06/2008
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2014 - 03/2008
4Reperfusion Injury
03/2011 - 03/2004
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 02/2010
3Colonic Neoplasms (Colon Cancer)
02/2019 - 04/2005
3Thrombocytopenia (Thrombopenia)
02/2019 - 01/2004
3Necrosis
10/2017 - 10/2004
3Acute Cholecystitis
06/2017 - 01/2008
3Carcinogenesis
01/2016 - 07/2003
3Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2015 - 11/2008

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
08/2021 - 08/2004
17GemcitabineFDA Link
10/2019 - 10/2003
15Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2006
12Cisplatin (Platino)FDA LinkGeneric
11/2017 - 04/2002
12Fluorouracil (Carac)FDA LinkGeneric
01/2014 - 06/2002
11Messenger RNA (mRNA)IBA
03/2023 - 01/2003
8AntigensIBA
12/2015 - 08/2002
8CytokinesIBA
09/2015 - 03/2004
8Interleukin-6 (Interleukin 6)IBA
04/2015 - 01/2002
7Indicators and Reagents (Reagents)IBA
04/2022 - 11/2008
7MucinsIBA
03/2014 - 01/2008
6Tumor Biomarkers (Tumor Markers)IBA
02/2019 - 08/2008
5CarbohydratesIBA
11/2020 - 05/2005
5Small Interfering RNA (siRNA)IBA
08/2020 - 11/2008
5EnzymesIBA
11/2016 - 04/2002
5Monoclonal AntibodiesIBA
04/2005 - 03/2002
4TOR Serine-Threonine KinasesIBA
09/2021 - 05/2007
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012 - 05/2003
4NF-kappa B (NF-kB)IBA
09/2010 - 03/2004
4Oxygen (Dioxygen)IBA
08/2008 - 09/2002
4doxifluridineIBA
04/2005 - 07/2002
3CA-19-9 Antigen (CA 19-9 Antigen)IBA
11/2020 - 05/2011
3InterferonsIBA
07/2019 - 01/2014
3Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2019 - 11/2015
3ProteomeIBA
08/2017 - 01/2011
3Cadherins (E-Cadherin)IBA
05/2017 - 05/2005
3DNA (Deoxyribonucleic Acid)IBA
01/2017 - 07/2008
3EverolimusFDA Link
11/2016 - 04/2010
3Transcription Factors (Transcription Factor)IBA
01/2016 - 11/2008
3perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA
11/2015 - 01/2008

Therapy/Procedure

53Therapeutics
03/2024 - 03/2002
50Hepatectomy
05/2023 - 05/2003
49Drug Therapy (Chemotherapy)
10/2022 - 03/2002
23Pancreaticoduodenectomy
01/2019 - 03/2002
19Neoadjuvant Therapy
01/2017 - 04/2002
16Pancreatectomy
02/2020 - 10/2004
11Stents
02/2017 - 10/2005
10Operative Surgical Procedures
01/2019 - 01/2002
9Adjuvant Chemotherapy
01/2020 - 07/2002
9Segmental Mastectomy (Lumpectomy)
11/2015 - 01/2007
8Cholecystectomy
02/2019 - 01/2007
8Liver Transplantation
01/2017 - 07/2005
7Radiotherapy
10/2020 - 09/2002
7Lymph Node Excision (Lymph Node Dissection)
11/2015 - 01/2004
6Heavy Ion Radiotherapy
03/2024 - 11/2015
5Splenectomy
01/2018 - 11/2002
5Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump)
01/2011 - 07/2005
5Coronary Artery Bypass (Coronary Artery Bypass Surgery)
03/2009 - 01/2004
4Operative Time
07/2019 - 01/2005
4Gastrectomy
02/2019 - 01/2003
4Colectomy
02/2019 - 11/2009
4Laparoscopic Cholecystectomy
06/2017 - 01/2008
4Laparotomy
05/2017 - 03/2005
4Ligation
07/2012 - 12/2002
3Transplantation
09/2017 - 03/2011
3Aftercare (After-Treatment)
03/2017 - 01/2012
3Catheters
01/2016 - 07/2005